XTL Biopharmaceuticals Reports Second Quarter 2015 Results
Go back to XTL Biopharmaceuticals Reports Second Quarter 2015 Results| SPDR S&P TELECOM ETF (NYSE: XTL) | Delayed: 220.96 -0.52 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.48 | 52 Week High | $67.19 | |||
| Open | $221.70 | 52 Week Low | $47.03 | |||
| Day High | $222.18 | P/E | N/A | |||
| Day Low | $220.86 | EPS | $0.00 | |||
| Volume | 47,425 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.60 -0.18 (6.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $1.75 | |||
| Open | $2.56 | 52 Week Low | $0.64 | |||
| Day High | $2.74 | P/E | N/A | |||
| Day Low | $2.56 | EPS | $0.00 | |||
| Volume | 6,131 | |||||

